AU2003278978A1 - Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors - Google Patents

Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors

Info

Publication number
AU2003278978A1
AU2003278978A1 AU2003278978A AU2003278978A AU2003278978A1 AU 2003278978 A1 AU2003278978 A1 AU 2003278978A1 AU 2003278978 A AU2003278978 A AU 2003278978A AU 2003278978 A AU2003278978 A AU 2003278978A AU 2003278978 A1 AU2003278978 A1 AU 2003278978A1
Authority
AU
Australia
Prior art keywords
migraine
macrolide
prophylactic
therapeutic treatment
related diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278978A
Other versions
AU2003278978A8 (en
Inventor
Heribert Bohlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axiogenesis AG
Cell Center Cologne GmbH
Original Assignee
Axiogenesis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axiogenesis AG filed Critical Axiogenesis AG
Publication of AU2003278978A8 publication Critical patent/AU2003278978A8/en
Publication of AU2003278978A1 publication Critical patent/AU2003278978A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003278978A 2002-06-25 2003-06-25 Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors Abandoned AU2003278978A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10228326.5 2002-06-25
DE10228326A DE10228326A1 (en) 2002-06-25 2002-06-25 Use of macrolide and / or tetracycline compounds and / or gyrase inhibitor-containing preparations for the prophylaxis and therapeutic treatment of migraines and migraine-related diseases
PCT/EP2003/006703 WO2004000329A1 (en) 2002-06-25 2003-06-25 Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors

Publications (2)

Publication Number Publication Date
AU2003278978A8 AU2003278978A8 (en) 2004-01-06
AU2003278978A1 true AU2003278978A1 (en) 2004-01-06

Family

ID=29761390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278978A Abandoned AU2003278978A1 (en) 2002-06-25 2003-06-25 Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors

Country Status (3)

Country Link
AU (1) AU2003278978A1 (en)
DE (1) DE10228326A1 (en)
WO (1) WO2004000329A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2329828A1 (en) * 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of ischaemia

Also Published As

Publication number Publication date
AU2003278978A8 (en) 2004-01-06
WO2004000329A1 (en) 2003-12-31
DE10228326A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2002351397A1 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1692085A4 (en) Inhibition of fgfr3 and treatment of multiple myeloma
SI1487541T1 (en) Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
AU2003291342A1 (en) Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
AU2003297460A1 (en) TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS
AU2002352533A1 (en) Methods and compositions for treatment of gastric diseases
AU2003229923A1 (en) Curcumin for the prevention and/or treatment of tissue damage
AU2003291480A1 (en) Composition for the prevention and treatment of inflammation of the ear
EP1531828A4 (en) Methods of treating bacterial infections and diseases associated therewith
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2003287909A1 (en) Electro-therapeutic device and method of electro-therapeutic treatment
AU2003260778A1 (en) Treatment of pipes
HK1062810A1 (en) Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease
AU2003273762A1 (en) Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
AU2003270625A1 (en) Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing
AU2002323106A1 (en) Treatment and prevention of heat shock protein-associated diseases and conditions
AU2003278978A1 (en) Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003270815A1 (en) Treatment of irritable bowel syndrome and related bowel diseases
AU2002305488A1 (en) Combined treatments and methods of treatment of mycoplasma and mycoplasma-like organism infections
AU2001226609A1 (en) Method and formulation for treatment of vasoconstriction
AU2002311845A1 (en) Methods of treating intestinal inflammation
AU2003216810A1 (en) Combination ofa cdk inhibitor and 5-fu for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase